Inhibiting fatty acid synthase (FASN) enzyme has been shown to decrease lipogenesis, and as a result the expression of glioblastoma stem cell (GSC) markers such as CD133, SOX2, and nestin, as well as cell proliferation and migration. Here, FASN is linked to glioblastoma.